journal article·2025-05-07Open access

Förster Resonance Energy Transfer (FRET) Demonstrates In Vitro Chitosan-Coated Nanocapsules Suitability for Intranasal Brain Delivery

Maria Alleva, Zsuzsa Baranyai, Natalia Esteban-Pérez, Pablo Martínez-Vicente, Rafael Martín-Rapún, María Moros, Jesús Martínez de la Fuente

ACS Applied Materials & Interfaces· Volume 17· Issue 18

Abstract

Intranasal drug delivery to the brain offers a promising strategy to overcome biological barriers. Chitosan-coated nanoemulsion-based nanocapsules demonstrate significant potential due to their mucoadhesive properties, ability to permeate epithelial cells, and ability to solubilize poorly water-soluble drugs, making them ideal candidates for bypassing the blood-brain barrier and overcoming the nasal mucosa. To ensure effective drug delivery, it is critical to assess the integrity of these nanocapsules during their transit across such barriers. In this study, we employed Förster resonance energy transfer to track the structural integrity of nanocapsules during transport. A simplified in vitro model was established using Calu-3 cells to mimic the mucosal epithelial barrier and Balb-c 3T3 fibroblasts as target cells. Our findings demonstrated that the nanoemulsion core of the nanocapsules successfully crossed the in vitro epithelial barrier and reached target cells while maintaining its structural integrity. These results validate the potential of chitosan-coated nanocapsules as a robust platform for the intranasal delivery of drugs to the brain.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · RNA Interference and Gene Delivery · Proteins in Food Systems

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Instituto de Nanociencia y Materiales de Aragón (INMA)

CSIC-Universidad de Zaragoza

Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN)

Departamento de Bioquímica y Biología Molecular y Celular, Facultad de Ciencias de la Salud y el Deporte

Universidad de Zaragoza

Funding

Gobierno de Arag?n · Ministerio de Ciencia, Innovaci?n y Universidades · European Regional Development Fund · HORIZON EUROPE Marie Sklodowska-Curie Actions · NextGenerationEU · Consorcio Centro de Investigaci?n Biom?dica en Red/Instituto de Salud Carlos III

References (46)

Show source-provided references
1. 10.1016/j.ijbiomac.2014.08.05210.1016/j.ijbiomac.2014.08.052 ↗
2. 10.1016/j.jconrel.2014.06.05310.1016/j.jconrel.2014.06.053 ↗
3. 10.1016/j.jconrel.2018.05.01110.1016/j.jconrel.2018.05.011 ↗
4. 10.1016/j.ejpb.2023.01.01310.1016/j.ejpb.2023.01.013 ↗
5. 10.3390/molecules2310266110.3390/molecules23102661 ↗
6. 10.1016/j.carbpol.2006.01.00110.1016/j.carbpol.2006.01.001 ↗
7. 10.1124/jpet.301.1.39110.1124/jpet.301.1.391 ↗
8. 10.3797/scipharm.1208-1810.3797/scipharm.1208-18 ↗
9. 10.1039/C6NR07581A10.1039/C6NR07581A ↗
10. 10.3390/polym1319325610.3390/polym13193256 ↗
11. 10.3390/jfb303061510.3390/jfb3030615 ↗
12. 10.15171/apb.2019.02310.15171/apb.2019.023 ↗
13. 10.1016/j.brainresbull.2018.10.00910.1016/j.brainresbull.2018.10.009 ↗
14. 10.1016/j.jddst.2024.10639010.1016/j.jddst.2024.106390 ↗
15. 10.1016/j.jconrel.2014.05.00310.1016/j.jconrel.2014.05.003 ↗
16. 10.1021/acs.biomac.1c0077610.1021/acs.biomac.1c00776 ↗
17. 10.3390/pr709061710.3390/pr7090617 ↗
18. 10.1016/j.cocis.2005.06.00410.1016/j.cocis.2005.06.004 ↗
19. 10.1038/s41578-019-0161-910.1038/s41578-019-0161-9 ↗
20. 10.3390/md1410017510.3390/md14100175 ↗
21. 10.1016/j.cej.2017.12.11010.1016/j.cej.2017.12.110 ↗
22. 10.1186/s12951-018-0439-x10.1186/s12951-018-0439-x ↗
23. 10.2217/nnm-2018-049610.2217/nnm-2018-0496 ↗
24. 10.3390/jcm901008910.3390/jcm9010089 ↗
25. 10.1016/j.jconrel.2013.06.01410.1016/j.jconrel.2013.06.014 ↗
26. 10.1016/j.jconrel.2017.03.00510.1016/j.jconrel.2017.03.005 ↗
27. 10.1016/j.addr.2019.04.00910.1016/j.addr.2019.04.009 ↗
28. 10.3390/ijms1604671810.3390/ijms16046718 ↗
29. 10.1093/jmicro/dft03710.1093/jmicro/dft037 ↗
30. 10.1002/marc.20220042110.1002/marc.202200421 ↗
31. 10.1016/j.jconrel.2022.06.04810.1016/j.jconrel.2022.06.048 ↗
32. 10.1016/j.biomaterials.2014.02.05310.1016/j.biomaterials.2014.02.053 ↗
33. 10.1002/adhm.20200128910.1002/adhm.202001289 ↗
34. 10.3390/ijms2121801910.3390/ijms21218019 ↗
35. 10.1021/mp500439c10.1021/mp500439c ↗
36. 10.1021/jacs.1c1354710.1021/jacs.1c13547 ↗
37. 10.1016/j.jddst.2024.10556410.1016/j.jddst.2024.105564 ↗
38. 10.1016/j.biopha.2022.11345010.1016/j.biopha.2022.113450 ↗
39. 10.1016/j.nantod.2017.12.00610.1016/j.nantod.2017.12.006 ↗
40. 10.1063/1.500420510.1063/1.5004205 ↗
41. 10.1039/D3SC06651G10.1039/D3SC06651G ↗
42. 10.1080/17458080.2011.60212010.1080/17458080.2011.602120 ↗
43. 10.1002/wnan.146710.1002/wnan.1467 ↗
44. 10.1021/acsabm.8b0075410.1021/acsabm.8b00754 ↗
45. 10.1016/j.drudis.2014.01.01110.1016/j.drudis.2014.01.011 ↗
46. 10.1016/j.apsb.2019.10.00210.1016/j.apsb.2019.10.002 ↗